Most Recent

image: Schizophrenia and the Synapse

Schizophrenia and the Synapse

By | January 27, 2016

Genetic evidence suggests that overactive synaptic pruning drives development of schizophrenia.

5 Comments

image: More CRISPR Improvements

More CRISPR Improvements

By | January 25, 2016

Researchers at the University of California, Berkeley, boost the CRISPR/Cas9 system’s gene-editing success rate in short pieces of DNA.

0 Comments

image: Cross-Reactive Ebola Antibodies

Cross-Reactive Ebola Antibodies

By | January 21, 2016

Human monoclonal antibodies induced during Ebola infection are able to neutralize related viral species, scientists show. 

0 Comments

image: Planning for the Next Ebola Outbreak

Planning for the Next Ebola Outbreak

By | January 20, 2016

A public-health nonprofit and an international drugmaker team up to stockpile hundreds of thousands of doses of a promising vaccine and to speed along the approval process.

0 Comments

image: Nutrient-Control for GM Bacteria

Nutrient-Control for GM Bacteria

By | January 20, 2016

Genetically modified bacteria that don’t survive unless given an unnatural amino acid could serve as a new control measure to protect wild organisms and ecosystems against accidental release. 

1 Comment

image: Another Role for ApoE?

Another Role for ApoE?

By | January 20, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

3 Comments

image: Mutant Mosquitoes Deployed to Stop Zika, Dengue

Mutant Mosquitoes Deployed to Stop Zika, Dengue

By | January 19, 2016

A Brazilian town will ramp up the release of insects engineered to shrink mosquito populations.

0 Comments

image: GM Paper Flagged by Politician Retracted

GM Paper Flagged by Politician Retracted

By | January 18, 2016

One of three suspect publications from a group of scientists in Italy is pulled for plagiarism while an investigation is ongoing.

0 Comments

image: Cord Blood Cells Foretell Food Allergy

Cord Blood Cells Foretell Food Allergy

By | January 13, 2016

Scientists link an immune phenotype present at birth to the development of food allergies a year later.

2 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

Popular Now

  1. Can Young Stem Cells Make Older People Stronger?
  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Two Dozen House Republicans Do an About-Face on Tuition Tax
  4. CRISPR to Debut in Clinical Trials